| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702583 | Urologic Oncology: Seminars and Original Investigations | 2017 | 9 Pages |
Abstract
Accounting for intratumor and intertumor heterogeneity with better sampling of cancer tissue is needed. This will hopefully lead to improved identification of driver mutations and actionable targets. Only then, we can move past the one-size-fits-all approach toward personalized treatment based on each individual׳s molecular profile.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Alp Tuna M.D., David J. B.A., Kyle A. M.D., Shalini Singh Ph.D., John P. M.D., Ketan K. M.D.,